The Cambridge, Mass., biotechnology company on Thursday said it received a notice of allowance from the U.S. Patent and Trademark Office regarding the drug candidate, ED-003, which is intended to ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

RFK Jr. says antidepressants could cause school shootings and are 'harder to get off' of than heroin. Experts say he's 'way off base.' ...

People receiving talking therapy for mild to severe depression reported greater improvements to their symptoms when also taking creatine compared with those on a placebo ...

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according to study findings.

A compelling new study is building on a growing body of evidence showing a common exercise supplement used to build muscle ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Over the last decade, the use of psychedelic substances has evolved from taboo to be considered by many a legitimate ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Melatonin isn't the only sleep aid out there. The best magnesium supplements might be your key to quality sleep.

Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...